Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies A Puda, JD Milosevic, T Berg, T Klampfl, AS Harutyunyan, B Gisslinger, ... American journal of hematology 87 (3), 245-250, 2012 | 126 | 2012 |
Clinical significance of genetic aberrations in secondary acute myeloid leukemia JD Milosevic, A Puda, L Malcovati, T Berg, M Hofbauer, A Stukalov, ... American journal of hematology 87 (11), 1010-1016, 2012 | 100 | 2012 |
Association of Bax expression and Bcl2/Bax ratio with clinical and molecular prognostic markers in chronic lymphocytic leukemia K Vucicevic, V Jakovljevic, N Colovic, N Tosic, T Kostic, I Glumac, ... Journal of medical biochemistry 35 (2), 150, 2016 | 61 | 2016 |
Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia L Dokmanovic, J Urosevic, D Janic, N Jovanovic, B Petrucev, N Tosic, ... Therapeutic drug monitoring 28 (6), 800-806, 2006 | 60 | 2006 |
Functional analysis of the role of the TPMT gene promoter VNTR polymorphism in TPMT gene transcription B Zukic, M Radmilovic, M Stojiljkovic, N Tosic, F Pourfarzad, ... Pharmacogenomics 11 (4), 547-557, 2010 | 51 | 2010 |
Optimization of PCR Conditions for Amplification of GC‐Rich EGFR Promoter Sequence J Obradovic, V Jurisic, N Tosic, J Mrdjanovic, B Perin, S Pavlovic, ... Journal of clinical laboratory analysis 27 (6), 487-493, 2013 | 48 | 2013 |
Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia N Colovic, N Tosic, S Aveic, M Djuric, N Milic, V Bumbasirevic, M Colovic, ... Annals of hematology 86, 741-747, 2007 | 48 | 2007 |
Molecular and phenotypic characteristics of patients with phenylketonuria in Serbia and Montenegro M Stojiljkovic, J Jovanovic, M Djordjevic, S Grkovic, M Cvorkov Drazic, ... Clinical genetics 70 (2), 151-155, 2006 | 46 | 2006 |
A gene expression profile associated with relapse of cytogenetically normal acute myeloid leukemia is enriched for leukemia stem cell genes H Hackl, K Steinleitner, K Lind, S Hofer, N Tosic, S Pavlovic, N Suvajdzic, ... Leukemia & lymphoma 56 (4), 1126-1128, 2015 | 44 | 2015 |
Polymorphisms of tumor-necrosis factor-α− 308 and lymphotoxin-α+ 250: Possible modulation of susceptibility to apoptosis in chronic lymphocytic leukemia and non-Hodgkin … T Jevtovic-Stoimenov, G Kocic, D Pavlovic, L MaČukanovic-Golubović, ... Leukemia & lymphoma 49 (11), 2163-2169, 2008 | 42 | 2008 |
Expression of bacteriocin LsbB is dependent on a transcription terminator G Uzelac, M Miljkovic, J Lozo, Z Radulovic, N Tosic, M Kojic Microbiological research 179, 45-53, 2015 | 40 | 2015 |
Clinical features of the most common fusion genes in childhood acute lymphoblastic leukemia J Lazic, N Tosic, L Dokmanovic, N Krstovski, P Rodic, S Pavlovic, D Janic Medical Oncology 27, 449-453, 2010 | 38 | 2010 |
Use of Wilms tumor 1 gene expression as a reliable marker for prognosis and minimal residual disease monitoring in acute myeloid leukemia with normal karyotype patients I Marjanovic, T Karan-Djurasevic, M Ugrin, M Virijevic, A Vidovic, D Tomin, ... Clinical Lymphoma Myeloma and Leukemia 17 (5), 312-319, 2017 | 36 | 2017 |
Gene mutation profiles in primary diffuse large B cell lymphoma of central nervous system: next generation sequencing analyses M Todorovic Balint, J Jelicic, B Mihaljevic, J Kostic, B Stanic, B Balint, ... International Journal of Molecular Sciences 17 (5), 683, 2016 | 36 | 2016 |
Molecular genetics and genotype-based estimation of BH4-responsiveness in Serbian PKU patients: spotlight on phenotypic implications of p. L48S M Djordjevic, K Klaassen, A Sarajlija, N Tosic, B Zukic, B Kecman, ... JIMD Reports–Case and Research Reports, 2012/6, 49-58, 2013 | 35 | 2013 |
Expression of Bcl2L12 in chronic lymphocytic leukemia patients: association with clinical and molecular prognostic markers T Karan-Djurasevic, V Palibrk, B Zukic, V Spasovski, I Glumac, M Colovic, ... Medical Oncology 30, 1-5, 2013 | 27 | 2013 |
Acute myeloid leukemia with NUP98–HOXC13 fusion and FLT3 internal tandem duplication mutation: case report and literature review N Tos̆ić, M Stojiljković, N Colović, M C̆olović, S Pavlović Cancer genetics and cytogenetics 193 (2), 98-103, 2009 | 27 | 2009 |
Immunotoxicity of epicutaneously applied anticoagulant rodenticide warfarin: evaluation by contact hypersensitivity to DNCB in rats M Kataranovski, M Vlaški, D Kataranovski, N Tošić, S Mandić-Radić, ... Toxicology 188 (1), 83-100, 2003 | 27 | 2003 |
TPMT gene expression is increased during maintenance therapy in childhood acute lymphoblastic leukemia patients in a TPMT gene promoter variable number of … N Kotur, L Dokmanovic, D Janic, B Stankovic, N Krstovski, N Tosic, ... Pharmacogenomics 16 (15), 1701-1712, 2015 | 25 | 2015 |
Incidence of FLT3 and nucleophosmin gene mutations in childhood acute myeloid leukemia: Serbian experience and the review of the literature N Krstovski, N Tosic, D Janic, L Dokmanovic, M Kuzmanovic, V Spasovski, ... Medical Oncology 27, 640-645, 2010 | 25 | 2010 |